TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹9,392 Cr | ₹5,623 Cr | ₹5,611 Cr | ₹5,314 Cr | ₹5,165 Cr |
What is the latest Total Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹9,392 Cr |
| Mar2025 | ₹5,623 Cr |
| Mar2024 | ₹5,611 Cr |
| Mar2023 | ₹5,314 Cr |
| Mar2022 | ₹5,165 Cr |
How is Total Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,392 Cr | 67.04 | |
| Mar2025 | ₹5,623 Cr | 0.20 | |
| Mar2024 | ₹5,611 Cr | 5.60 | |
| Mar2023 | ₹5,314 Cr | 2.88 | |
| Mar2022 | ₹5,165 Cr | - | |
Compare Total Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹181,641.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.9% |
2.1% |
30.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses